NEW YORK--(BUSINESS WIRE)--Neuro-Hitech, Inc. (OTC BB: NHPI), a biopharmaceutical company focused on the development and commercialization of next-generation compounds against proven targets for neurodegenerative diseases, today announced the final closing on $5,600,000 of its securities in a private placement of its common shares and warrants. In connection with the private placement approximately 1.1 million shares of the Company’s common stock and approximately 550,000 warrants will be issued. The final offering occurred on March 15, 2007 and includes the $3.1 million previously announced.
